Projects

2024-27

* Title: Personalized medicine through the application of targeted gene therapy to improve the diagnosis and treatment of Osteogenesis Imperfecta

Funding entity: XXI Call for Health Research Grants from the Mutua Madrileña Foundation

From 01/10/2024 to 30/09/2027

2024-26

* Title: Advancing in the knowledge of Char Syndrome, genotype-phenotype correlation

Funding entity: Ernesto Sánchez Villares Foundation

From 18/06/2024 to 17/01/2026

2024-26

* Title: Integractomy: Integration of multi-omics and image data through the application of Artificial Intelligence algorithms for diagnosis and identification of molecular pathways involved in the development of Rare Diseases

Financing entity: Division of health and consumption of the Junta de Andalucía Goverment

From 01/01/2024 to 31/10/2026

2023

* Title: Molecular bases and functional consequences of germline variants in genes that cause RASopathies as predictors of symptoms in the pediatric population

Financing entity: Regional Health Management of Castilla y León

From 19/04/2023 to 31/12/2023

2021-23

* Title: Molecular genetics and its relationship with neurological alterations in pediatric patients with Rasopathy.

Financing entity: Alicia Koplowitz Foundation

From 01/11/2021 to 31/10/2023

2021-23

* Title: Rasopathies, molecular genetics and their relationship with endocrinological and anthropometric alterations in patients from Castilla y León.

Financing entity: Spanish Society of Pediatric Endocrinology

From 01/07/2021 to 30/06/2023

2021

* Title: Bioinformatic analysis and molecular characterization of a pathogenic variant of the SPRED1 gene that causes Legius syndrome.

Financing entity: University of Salamanca

From desde 01/02/2021 to 31/12/2021

2020

* Title: Precision personalized medicine applied to patients diagnosed with Rare Diseases in Castilla y León. Molecular bases of the genotypic variability of neurofibromatosis type I (NF1) and related syndromes.

Financing entity: SACYL. Regional Health Management

From 01/10/2019 to 31/12/2020

2016

* Title: Function, diagnostic value and pharmacological inhibition of TC21, a new oncogenic driver

Financing entity: Asociación Española Contra el Cáncer (AECC)

From 01/11/2016 to 31/10/2021

* Title: Validación genética y aplicaciones terapéutico-traslacional de nuevos drivers oncogénicos

Financing entity: Fondo Europeo de Desarrollo Regional (FEDER)

From 01/10/2016 to 22/11/2017

* Title: Chemotaxis in Dictyostelium discoidem: an integrative approach

Financing entity: National Institute of Health (NIH)

From 01/07/2016 to 31/07/2017

2012

* Title: Signalling processes in Dictyostelium

Financing entity: National Institute of Health (NIH)

From 21/05/2012 to 31/01/2016

2010

* Title: Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells

Financing entity: National Institute of Health (NIH)

From 30/09/2010 to 30/06/2015